收藏切换
The impact of national centralized drug procurement on the clinical use of anticoagulant and antiplatelet drug in a hospital
收藏切换
Peng CHEN, Yuehao ZHU, Fang CAO, Yang LI
World Clinical Drug | 2025, 46(8) : 809 - 816
Less
收藏切换
World Clinical Drug | 2025, 46(8): 809-816
The impact of national centralized drug procurement on the clinical use of anticoagulant and antiplatelet drug in a hospital
Full
Peng CHEN, Yuehao ZHU, Fang CAO, Yang LI
Affiliations
  • Department of Pharmacy, The Second People's Hospital of Bengbu City, Bengbu 233000, Anhui Province, China
Published: 2025-08-10 doi: 10.13683/j.wph.2025.08.012
Outline
收藏切换
Objective

To investigate the impact of the national centralized drug procurement(NCGPO) policy on the clinical use of anticoagulant and antiplatelet drugs in a hospital, and to provide evidence for optimizing pharmaceutical management.

Methods

Data on anticoagulant and antiplatelet drug usage were collected for one year before and after the implementation of the first, third, fourth, fifth, seventh, and eighth batches of NCGPO in a hospital, covering 11 selected drugs. The defined daily doses(DDDs), usage proportion of similar drugs, price reduction, expenditure, defined daily cost(DDC), and cost savings were compared before and after NCGPO.

Results

After NCGPO implementation, the unit prices of 28 drugs (including 11 selected drugs) decreased significantly. The DDDs and usage proportion of selected drugs were higher than those of non-NCGPO drugs. The usage of clopidogrel, ticagrelor, dabigatran etexilate, and rivaroxaban(10 mg)increased notably, with a higher proportion in their therapeutic categories. The DDC of all NCGPO drugs decreased, with the largest reduction observed in rivaroxaban tablets(10 mg)(99.20%). Cost savings per batch ranged from 24 200 to 2 814 400 CNY, totaling 8 594 100 CNY.

Conclusion

The NCGPO policy achieved “increased usage and reduced prices,”effectively alleviating patients’ financial burden and enhancing the medical security system.

anticoagulant drugs  /  national centralized drug procurement  /  antiplatelet drugs  /  efined daily dose system  /  efined daily dose cost
陈鹏, 朱月皓, 曹芳, 李阳. 国家药品集中采购对某院抗凝血药和抗血小板药物临床使用的影响. 世界临床药物, 2025 , 46 (8) : 809 -816 . DOI: 10.13683/j.wph.2025.08.012
Peng CHEN, Yuehao ZHU, Fang CAO, Yang LI. The impact of national centralized drug procurement on the clinical use of anticoagulant and antiplatelet drug in a hospital[J]. World Clinical Drug, 2025 , 46 (8) : 809 -816 . DOI: 10.13683/j.wph.2025.08.012
Year 2025 volume 46 Issue 8
63
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.08.012
  • Receive Date:2025-01-15
  • Online Date:2026-11-09
  • Published:2025-08-10
Article Data
Affiliations
History
  • Received:2025-01-15
Affiliations
    Department of Pharmacy, The Second People's Hospital of Bengbu City, Bengbu 233000, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.08.012
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT